PPMD Community



Members: 72
Latest Activity: Jul 23

Comment Wall


You need to be a member of Duplications to add comments!

Comment by Gabija on July 23, 2017 at 3:31am

My two sons age are 8 month and 9 years. Duplication of Exons 18.I am a carrier..;(

Comment by Sai Chand. Gurujala on February 10, 2017 at 4:26am

My Nephew age is 7.5 years.

Hemizygous Duplication of Exons 2 - 4.
MLPA probe ratio : 1.83 - 1.98
CPK level - 12100

Please can anybody tell, When the complete treatment can be expected please

Comment by Ana on May 10, 2016 at 1:56pm

Still Here

Comment by Katherine Blake on May 10, 2016 at 11:30am

He's 12.  Just sent request.  

Comment by Marilyn Ash on May 10, 2016 at 11:27am
Friend me on Facebook and I can add you. I like Duchenne Under Ten, DMD moms, and DMD Army. There's another one that I like but I can't recall the title. It's really long. How old is your son?
Comment by Katherine Blake on May 10, 2016 at 11:23am

Marilyn Ash - what FB groups are you in?  I am only just getting involved on FB and am behind the curve.  

Comment by Marilyn Ash on May 10, 2016 at 11:13am
I'm still here, too. I usually participate more on the Facebook groups. It's been a year since dx and it still seems like we just got the phone call yesterday. Any Dup2 kiddos out there?
Comment by Katherine Blake on May 10, 2016 at 11:04am

Still here...still plugging away.  You aren't alone.  I don't comment much because sometimes it's hard.  But, still here.  :)  

Comment by Cathy Johnson on May 10, 2016 at 11:01am

Just checking in to see how many of you are still out there.  Duchenne is a lonely place and we are such a small group.

Comment by dietf on March 7, 2016 at 2:43am
A re-comment after two years. My sons are 8.5 and 6. Now our elder boy has problems with his legs. He has gower's sign. We have duplication on exon 39 and still don't have muscle biopsy. Does anyone have knowledge about utrophin drug smt c1100. Will it be a cure for us?

Members (72)


© 2017   Created by PPMD.   Powered by

Badges  |  Report an Issue  |  Privacy Policy  |  Terms of Service